Plandai Biotechnology Completes Test Stage 1 of Senteeko Phytofare Factory in South Africa

Plandaí Biotechnology, Inc. (OTCMKTS:PLPL) completed and successfully tested Stage 1 of its state-of-the-art production facility on the Senteeko Tea Estate in South Africa. Once fully commissioned, the factory will produce the company’s proprietary Phytofare™ Catechin Complex, a highly bioavailable green tea extract. The facility is designed to also process lemons, which will be used to produce a Limonoid Glycoside Complex.

As quoted in the press release:

The company also disclosed that Stage 2 is scheduled to be completed and tested on March 21 with Stage 3 brought online in early April. The final commissioning will take place over April as the company’s engineers and scientists fine-tune the equipment, train staff, and test the output for conformity with the product profile.

At capacity, the Senteeko facility can process 400 hectares (988 acres) of live green tea, yielding a total of eight tons of Phytofare™ every month. The facility is designed to also process lemons, which will be used to produce a Limonoid Glycoside Complex. Most of the citrus line equipment has been delivered, though this segment of the facility will not be brought online until later in 2014, pending the completion of additional clinical trials.

Plandai Chairman and Chief Executive Officer Roger Duffield, said:

The Senteeko facility will shortly come online, representing the culmination of over ten years of painstaking research and development. As the video shows, Stage 1 is now operational, which allows us to render live plant matter into a slurry that is then pumped into Stage 2 where the molecule is opened up to release the phytonutrients. Stage 3 then separates the various components, removes the water, and yields high purity extract. All of the equipment is in place for Stages 2 and 3 with the electronics, computers and steam piping currently being installed.

Click here to read the Plandaí Biotechnology (OTCMKTS:PLPL) press release